1. Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications

   • Anvarsadat Kianmehr
   • Isabella Faraoni
   • Abdolkarim Mahrooz

   Review 03 May 2021 Pages: 1587 - 1598

   

2. Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study

   • Chuanfeng Zhang
   • Mengjiao Cao
   • Linfu Zhou

   Original Article 01 March 2021 Pages: 1599 - 1608

   

3. Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing

   • Christine C. Ginocchio
   • Carolina Garcia-Mondragon
   • and the EME Evaluation Program Collaborative

   Original Article Open access 02 March 2021 Pages: 1609 - 1622

   

4. Therapeutic efficacy of chitosan nanoparticles loaded with BCG-polysaccharide nucleic acid and ovalbumin on airway inflammation in asthmatic mice

   • Wentao Yang
   • Zhaohui Dong
   • Yanping Xie

   Original Article 05 March 2021 Pages: 1623 - 1631

   

5. Comparison of clinical characteristics and outcomes between respiratory syncytial virus and influenza-related pneumonia in China from 2013 to 2019

   • Liang Chen
   • Xiudi Han
   • Xiqian Xing

   Original Article 06 March 2021 Pages: 1633 - 1643

   

6. Incidence, clinical characteristics, risk factors and outcomes of meningoencephalitis in patients with COVID-19

   • Marcos Fragiel
   • Òscar Miró
   • on behalf of the Spanish Investigators on Emergency Situations TeAm (SIESTA) network

   Original Article 09 March 2021 Pages: 1645 - 1656

   

7. Short time to blood culture positivity in Enterococcus faecalis infective endocarditis

   • Karl Oldberg
   • Rebecca Thorén
   • Magnus Rasmussen

   Original Article Open access 09 March 2021 Pages: 1657 - 1664

   

8. Bloodstream infections in older population: epidemiology, outcome, and impact of multidrug resistance

   • Marine de Laroche
   • Lesly Fellous
   • Aurélien Dinh

   Original Article 10 March 2021 Pages: 1665 - 1672

   

9. Attributable mortality of ICU acquired bloodstream infections: a propensity-score matched analysis

   • Nicolas Massart
   • Guilhem Wattecamps
   • Pierre Fillatre

   Original Article 10 March 2021 Pages: 1673 - 1680

   

10. Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence

    • Lívia Custódio Pereira
    • Amabel Fernandes Correia
    • Yanna Karla de Medeiros Nóbrega

    Original Article Open access 13 March 2021 Pages: 1681 - 1693

    

11. Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples

    • Daniëlle A. T. Hanssen
    • Michiel Slaats
    • Inge H. M. van Loo

    Original Article Open access 17 March 2021 Pages: 1695 - 1703

12. Evaluation of the CARDS toxin and its fragment for the serodiagnosis of Mycoplasma pneumoniae infections

    • Guanhua Xue
    • Hanqing Zhao
    • Jing Yuan

    Original Article 18 March 2021 Pages: 1705 - 1711

    

13. Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran

    • Mostafa Salehi-Vaziri
    • Tahmineh Jalali
    • Amitis Ramezani

    Original Article 18 March 2021 Pages: 1713 - 1719

    

14. Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19

    • William Stokes
    • Byron M. Berenger
    • Graham Tipples

    Original Article 20 March 2021 Pages: 1721 - 1726

    

15. Antimicrobial stewardship experience in paediatrics: first-year activity report

    • Erika Silvestro
    • Raffaella Marino
    • Carlo Scolfaro

    Original Article 20 March 2021 Pages: 1727 - 1735

    

16. Changes in antimicrobial resistance and outcomes of health care–associated infections

    • Mehtap Aydın
    • Emel Azak
    • Önder Ergönül

    Brief Report 14 February 2021 Pages: 1737 - 1742

    

17. Evaluation of a novel rapid TRC assay for the detection of influenza using nasopharyngeal swabs and gargle samples

    • Norihito Kaku
    • Kohji Hashiguchi
    • Katsunori Yanagihara

    Brief Report 16 February 2021 Pages: 1743 - 1748

    

18. Evaluation of two rapid phenotypical tests—Alifax rapid AST colistin test and Rapid Polymyxin NP test—for detection of colistin resistance in Enterobacterales

    • Julija Germ
    • Katja Seme
    • Mateja Pirs

    Brief Report Open access 17 February 2021 Pages: 1749 - 1753

19. Ceftazidime-avibactam, meropenen-vaborbactam, and imipenem-relebactam in combination with aztreonam against multidrug-resistant, metallo-β-lactamase-producing Klebsiella pneumoniae

    • Sofia Maraki
    • Viktoria Eirini Mavromanolaki
    • Effie Scoulica

    Brief Report 17 February 2021 Pages: 1755 - 1759

20. KPC-12 with a L169M substitution in the Ω loop has reduced carbapenemase activity

    • Jiayuan Qin
    • Yu Feng
    • Zhiyong Zong

    Brief Report 17 February 2021 Pages: 1761 - 1766

    

21. Stepwise selection of mutation conferring fluroquinolone resistance: multisite MDR-TB cohort study

    • Jingtao Gao
    • Jian Du
    • Yu Pang

    Brief Report 18 February 2021 Pages: 1767 - 1771

    

22. Temocillin as an alternative treatment for acute bacterial cholangitis: a retrospective microbiology susceptibility-based study of 140 episodes

    • Sylvain Chawki
    • Aurélien Sokal
    • Victoire de Lastours

    Brief Report 20 February 2021 Pages: 1773 - 1777

    

23. Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar

    • Fatma Ben Abid
    • Clement K. M. Tsui
    • Ali S. Omrani

    Brief Report Open access 22 February 2021 Pages: 1779 - 1785

24. Annual variations of Haemophilus influenzae carriage among Hajj pilgrims

    • Van-Thuan Hoang
    • Thi-Loi Dao
    • Philippe Gautret

    Letter to the Editor 28 May 2021 Pages: 1787 - 1788

    

25. Correction to: An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy

    • Sahand Imani
    • Hergen Buscher
    • Indy Sandaradura

    Correction 17 June 2021 Pages: 1789 - 1789